189 related articles for article (PubMed ID: 19285355)
1. Boron neutron capture therapy for newly diagnosed glioblastoma.
Yamamoto T; Nakai K; Kageji T; Kumada H; Endo K; Matsuda M; Shibata Y; Matsumura A
Radiother Oncol; 2009 Apr; 91(1):80-4. PubMed ID: 19285355
[TBL] [Abstract][Full Text] [Related]
2. Boron neutron capture therapy for newly diagnosed glioblastoma: a pilot study in Tsukuba.
Yamamoto T; Nakai K; Tsurubuchi T; Matsuda M; Shirakawa M; Zaboronok A; Endo K; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S25-6. PubMed ID: 19375927
[TBL] [Abstract][Full Text] [Related]
3. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
[TBL] [Abstract][Full Text] [Related]
4. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
[TBL] [Abstract][Full Text] [Related]
5. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
[TBL] [Abstract][Full Text] [Related]
6. Boron neutron capture therapy combined with fractionated photon irradiation for glioblastoma: a recursive partitioning analysis of BNCT patients.
Nakai K; Yamamoto T; Aiyama H; Takada T; Yoshida F; Kageji T; Kumada H; Isobe T; Endo K; Matsuda M; Tsurubuchi T; Shibata Y; Takano S; Mizumoto M; Tsuboi K; Matsumura A
Appl Radiat Isot; 2011 Dec; 69(12):1790-2. PubMed ID: 21565517
[TBL] [Abstract][Full Text] [Related]
7. Boron neutron capture therapy using mixed epithermal and thermal neutron beams in patients with malignant glioma-correlation between radiation dose and radiation injury and clinical outcome.
Kageji T; Nagahiro S; Matsuzaki K; Mizobuchi Y; Toi H; Nakagawa Y; Kumada H
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1446-55. PubMed ID: 16750328
[TBL] [Abstract][Full Text] [Related]
8. Preliminary treatment planning and dosimetry for a clinical trial of neutron capture therapy using a fission converter epithermal neutron beam.
Kiger WS; Lu XQ; Harling OK; Riley KJ; Binns PJ; Kaplan J; Patel H; Zamenhof RG; Shibata Y; Kaplan ID; Busse PM; Palmer MR
Appl Radiat Isot; 2004 Nov; 61(5):1075-81. PubMed ID: 15308195
[TBL] [Abstract][Full Text] [Related]
9. Current practices and future directions of therapeutic strategy in glioblastoma: survival benefit and indication of BNCT.
Matsumura A; Yamamoto T; Tsurubuchi T; Matsuda M; Shirakawa M; Nakai K; Endo K; Tokuue K; Tsuboi K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S12-4. PubMed ID: 19375923
[TBL] [Abstract][Full Text] [Related]
10. L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a Phase I study.
Kankaanranta L; Seppälä T; Koivunoro H; Välimäki P; Beule A; Collan J; Kortesniemi M; Uusi-Simola J; Kotiluoto P; Auterinen I; Serèn T; Paetau A; Saarilahti K; Savolainen S; Joensuu H
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):369-76. PubMed ID: 21236605
[TBL] [Abstract][Full Text] [Related]
11. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer.
Kankaanranta L; Seppälä T; Koivunoro H; Saarilahti K; Atula T; Collan J; Salli E; Kortesniemi M; Uusi-Simola J; Mäkitie A; Seppänen M; Minn H; Kotiluoto P; Auterinen I; Savolainen S; Kouri M; Joensuu H
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):475-82. PubMed ID: 17689034
[TBL] [Abstract][Full Text] [Related]
12. Radiation injury of boron neutron capture therapy using mixed epithermal- and thermal neutron beams in patients with malignant glioma.
Kageji T; Nagahiro S; Mizobuchi Y; Toi H; Nakagawa Y; Kumada H
Appl Radiat Isot; 2004 Nov; 61(5):1063-7. PubMed ID: 15308193
[TBL] [Abstract][Full Text] [Related]
13. Boron neutron capture therapy for glioblastoma.
Yamamoto T; Nakai K; Matsumura A
Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
[TBL] [Abstract][Full Text] [Related]
14. Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008).
H-Stenstam B
Radiother Oncol; 2008 Aug; 88(2):287-8; author reply 288. PubMed ID: 18617284
[No Abstract] [Full Text] [Related]
15. Current clinical results of the Tsukuba BNCT trial.
Yamamoto T; Matsumura A; Nakai K; Shibata Y; Endo K; Sakurai F; Kishi T; Kumada H; Yamamoto K; Torii Y
Appl Radiat Isot; 2004 Nov; 61(5):1089-93. PubMed ID: 15308197
[TBL] [Abstract][Full Text] [Related]
16. Multifocal glioblastoma multiforme: prognostic factors and patterns of progression.
Showalter TN; Andrel J; Andrews DW; Curran WJ; Daskalakis C; Werner-Wasik M
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):820-4. PubMed ID: 17499453
[TBL] [Abstract][Full Text] [Related]
17. [Neutron capture therapy in the treatment of glioblastoma multiforme. Initial experience in the Czech Republic].
Honová H; Safanda M; Petruzelka L; Burian J; Marek M; Rejchrt J; Sus F; Tovarys F; Dbalý V; Honzátko J; Tomandl I; Mares V
Cas Lek Cesk; 2004; 143(1):44-7. PubMed ID: 15061119
[TBL] [Abstract][Full Text] [Related]
18. Neuropathological postmortem evaluation of BNCT for GBM.
H-Stenstam B; Pellettieri L; Sköld K; Rezaei A; Brun A
Acta Neurol Scand; 2007 Sep; 116(3):169-76. PubMed ID: 17714330
[TBL] [Abstract][Full Text] [Related]
19. Preservation of quality of life by preradiotherapy stereotactic radiosurgery for unresectable glioblastoma multiforme.
Kong DS; Nam DH; Lee JI; Park K; Kim JH
J Neurosurg; 2006 Dec; 105 Suppl():139-43. PubMed ID: 18503347
[TBL] [Abstract][Full Text] [Related]
20. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Chen AM; Chang S; Pouliot J; Sneed PK; Prados MD; Lamborn KR; Malec MK; McDermott MW; Berger MS; Larson DA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):825-30. PubMed ID: 17512132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
